The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis

BACKGROUND AND AIMS: The topically applied Toll-like receptor 9 [TLR9] agonist cobitolimod is a first-in-class DNA-based oligonucleotide with demonstrated therapeutic efficacy in clinical trials with ulcerative colitis [UC] patients. We here characterized its anti-inflammatory mechanism in UC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitt, Heike, Ulmschneider, Julia, Billmeier, Ulrike, Vieth, Michael, Scarozza, Patrizio, Sonnewald, Sophia, Reid, Stephen, Atreya, Imke, Rath, Timo, Zundler, Sebastian, Langheinrich, Melanie, Schüttler, Jürgen, Hartmann, Arndt, Winkler, Thomas, Admyre, Charlotte, Knittel, Thomas, Dieterich Johansson, Christine, Zargari, Arezou, Neurath, Markus F, Atreya, Raja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242005/
https://www.ncbi.nlm.nih.gov/pubmed/31630153
http://dx.doi.org/10.1093/ecco-jcc/jjz170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242005/
https://www.ncbi.nlm.nih.gov/pubmed/31630153
http://dx.doi.org/10.1093/ecco-jcc/jjz170

Ejemplares similares